Synonyms: DR-3355 | Levaquin® | Quinsair®
levofloxacin is an approved drug (FDA (1996), EMA (2015))
Compound class:
Synthetic organic
Comment: Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibacterial.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1996), EMA (2015)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
6708 | levofloxacin |
Synonyms |
DR-3355 | Levaquin® | Quinsair® |
Database Links | |
Specialist databases | |
Antibiotic DB | Levofloxacin |
Other databases | |
CAS Registry No. | 100986-85-4 (source: PubChem) |
ChEMBL Ligand | CHEMBL33 |
DrugBank Ligand | DB01137 |
DrugCentral Ligand | 1569 |
GtoPdb PubChem SID | 405560352 |
PubChem CID | 149096 |
RCSB PDB Ligand | LFX |
Search Google for chemical match using the InChIKey | GSDSWSVVBLHKDQ-JTQLQIEISA-N |
Search Google for chemicals with the same backbone | GSDSWSVVBLHKDQ |
Search PubMed clinical trials | levofloxacin |
Search PubMed titles | levofloxacin |
Search PubMed titles/abstracts | levofloxacin |
UniChem Compound Search for chemical match using the InChIKey | GSDSWSVVBLHKDQ-JTQLQIEISA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GSDSWSVVBLHKDQ-JTQLQIEISA-N |